Clinical Trial Update: A Cross Sectional Disease/Condition Focused Observational Study on Chronic Obstructive Pulmonary Disease (COPD)

View source ↗

Summary

A cross-sectional observational study focusing on Chronic Obstructive Pulmonary Disease (COPD) has been completed. The sponsor is AstraZeneca.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Status: COMPLETED